Molecular Mechanism of Neutrophil Necroptosis and Its Roles in RA Pathogenesis
NCT02385331 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2015-03-11
Summary
Neutrophils play a central role in innate immunity and are rapidly recruited to sites of infection and injury. Neutrophil apoptosis and necroptosis are essential for the inflammatory.This study is designed to investigate the cells and the molecular mechanisms of neutrophil necroptosis and apoptosis.
Conditions
- Healthy
Sponsors & Collaborators
-
The Third Affiliated Hospital of Southern Medical University
lead OTHER_GOV
Principal Investigators
-
ew Sun, doctor · Third Affiliated Hospital of Southern Medical University
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-03-31
- Primary Completion
- 2015-09-30
- Completion
- 2016-02-29
Countries
- China
Study Locations
More Related Trials
-
Effects of Nonsteroidal Anti-Inflammatory Drugs in Recurrence of Spondyloarthritis Patients After Remission
NCT03425812 ·Status: RECRUITING ·Phase: NA
-
A Study of GNC-038 Tetra-specific Antibody Injection in Patients With Rheumatoid Arthritis
NCT06857227 ·Status: RECRUITING ·Phase: PHASE1
-
99mTc-3PRGD2 SPECT/CT in Rheumatoid Arthritis Patients
NCT02723760 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Efficacy and Safety of Luo-Fu-Shan Plaster in Patients With Rheumatoid Arthritis
NCT04884880 ·Status: UNKNOWN ·Phase: NA
-
IL-6, IL-12, IL-15 and IL-23 Expression Levels in Rheumatoid Arthritis Patients
NCT06558305 ·Status: NOT_YET_RECRUITING
-
The Clinical Efficacy of Immunomodulators in RA Patients
NCT05626348 ·Status: RECRUITING ·Phase: PHASE4
-
The Role of Microbiome on Biological Therapy Efficacy in axSpA and RA
NCT04973787 ·Status: UNKNOWN
-
Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate
NCT00538902 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Ultrasonographic Monitoring of Response to Infliximab in Patients With Rheumatoid Arthritis
NCT01282528 ·Status: UNKNOWN ·Phase: PHASE4
-
Multiple Doses Escalation Study of SHR0302 in Rheumatoid Arthritis (RA) Patients
NCT02665910 ·Status: UNKNOWN ·Phase: PHASE1
-
A New Mode of Action of Anti-TNF, Reverse Signaling, in Rheumatoid Arthritis
NCT03216928 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Condition of Rheumatoid Arthritis After Treatment
NCT02157012 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in Korea
NCT01294722 ·Status: COMPLETED
-
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis
NCT01927263 ·Status: COMPLETED ·Phase: PHASE3
-
The Role of Tofacitinib in Steroid Withdrawal in Rheumatoid Arthritis
NCT04927000 ·Status: UNKNOWN ·Phase: PHASE4
-
Methotrexate Combined With Tofacitinib in Rheumatoid Arthritis
NCT06301373 ·Status: RECRUITING ·Phase: NA
-
The Efficacy of the Traditional Chinese Medicine Niubang Pill Combined With Methotrexate on Active Rheumatoid Arthritis
NCT03173040 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Neutropenia With TNF-α Inhibitors
NCT07237906 ·Status: COMPLETED
-
Certolizumab and Lower Extremity Lymph Flow in Rheumatoid Arthritis (RA)
NCT01098201 ·Status: COMPLETED
-
Identification of Novel Molecular Targets for Rheumatoid Arthritis Patients
NCT04201535 ·Status: UNKNOWN
-
An Open-label Study of GC012F in Rheumatoid Arthritis.
NCT07315503 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
A Study of Tocilizumab Plus Non-biological DMARD in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Non-biological DMARDs
NCT01034397 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective Cohort Study on Refractory Rheumatoid Arthritis
NCT07126431 ·Status: RECRUITING
-
Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy
NCT01463059 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of GenSci120 in Healthy Adult Participants in China.
NCT07040930 ·Status: RECRUITING ·Phase: PHASE1